BCL6 and diffuse large B-cell lymphoma: Bcl6, which is the most common oncogenic protein in DLBCL, has been identified as a client protein of HSP90 based on observations of how DLBCL cells respond to HSP90 inhibitors (Cerchietti et al., 2009; Calvo-Vidal et al., 2021).